Management of Metastatic Breast Cancer in Clinical Practice - Retrospective Study
The purpose of this study is to evaluate the incidence rate of progression of disease, to describe the diagnostic and clinical management in patients with Metastatic Breast Cancer in the clinical practice in Bulgaria.
Metastatic Breast Cancer
Number of progression events on a per patient-year-basis, Up to 2 years 5 months
Proportion of patients among study population who have not progressed at 12 and 18 months after they were diagnosed, Up to 2 years 5 months|Median and mean time interval that elapsed between diagnosis and first objective tumor progression (TTP) event and subsequent events, Up to 2 years 5 months|Median and mean time from the date of diagnosis to the date of breast cancer progression or death whichever occurred first, Up to 2 years 5 months
A Retrospective Cohort Study on Therapeutic Management of Metastatic Breast Cancer in Clinical Practice in Bulgaria